Anthem Blue Cross Connecticut Commercial Clinical Policy

Anthem Blue Cross Connecticut LAB.00044 Saliva-based Testing to Determine Drug-Metabolizer Status Form

Effective Date

04/12/2023

Last Reviewed

02/16/2023

Original Document

  Reference



LAB.00044 Saliva-based Testing to Determine Drug-Metabolizer Status

Subject:

Description/Scope

This document addresses the use of saliva-based testing to determine drug-metabolizer status. This document does not address the collection of saliva for genetic testing (for example, Genecept™ Assay).

Note: Please see the following related documents for additional information:

  • CG-GENE-11 Genotype Testing for Individual Genetic Polymorphisms to Determine Drug-Metabolizer Status
  • GENE.00010 Panel and other Multi-Gene Testing for Polymorphisms to Determine Drug-Metabolizer Status

Position Statement

Investigational and Not Medically Necessary:

Saliva-based testing to determine drug-metabolizer status is considered investigational and not medically necessary for all indications.